STVN
Stevanato Group S.p.A.
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$20.33
−1.02%Forward multiples
Based on analyst estimates
- P/E forward
- 26.21x
- P/E 2026E
- 28.70x
- P/E 2027E
- 23.97x
- P/E 2028E
- 20.29x
- P/S forward
- 3.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- 36.43x
- PEG TTM
- 0.94x
- Price / book
- 3.08x
- Price / sales
- 3.91x
- Price / cash flow
- 19.34x
Enterprise value
- Enterprise value
- $6.0B
- EV / sales
- 4.20x
- EV / EBITDA
- 18.89x
- EV / EBIT
- 26.13x
- Market cap
- $5.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026